Neuroscientist Joseph Takahashi to Deliver Sinauer Associates Lecture

University of Massachusetts Amherst's picture
Printer-friendly versionPrinter-friendly version

Joseph S. Takahashi, the Loyd B. Sands Distinguished Chair in Neuroscience and chairman of the neuroscience department at the University of Texas Southwestern, will deliver the fall Sinauer Associates Lecture “The 24-hour clock in our DNA” on Oct. 11 at 4 p.m. in S240 Integrative Learning Center.

The event is free to the public.

Takahashi has pioneered the use of forward genetics and positional cloning in the mouse as a tool for discovery of genes underlying neurobiology and behavior, and his discovery of the mouse and human clock genes led to a description of a conserved circadian clock mechanism in animals.

He is the author of more than 260 scientific publications and the recipient of many awards including the Honma Prize in Biological Rhythms Research, NSF Presidential Young Investigator Award, Searle Scholars Award, Bristol-Myers Squibb Unrestricted Grant in Neuroscience, and the C. U. Ariens Kappers Medal. He received the W. Alden Spencer Award in Neuroscience from Columbia University in 2001, was elected a Fellow of the American Academy of Arts and Sciences in 2000, a Member of the National Academy of Sciences in 2003 and a Member of the National Academy of Medicine in 2014.

Takahashi has served on a number of advisory committees for the National Institutes of Health, as well as scientific advisory boards for Eli Lilly and Company, Bristol-Myers Squibb Neuroscience Committee, the Genomics Research Institute for the Novartis Foundation, the Klingenstein Fund, the Searle Scholars Foundation, the McKnight Foundation, the Allen Institute for Brain Science, the Max Planck Institute for Biophysical Chemistry and the Restless Legs Syndrome Foundation.

He was a co-founder of Hypnion Inc., a biotech discovery company in Worcester that investigated sleep/wake neurobiology and pharmaceuticals (now owned by Eli Lilly and Co.). He is a co-founder of ReSet Therapeutics Inc., a biotech company that works on the role of clocks in metabolism.

Copy this html code to your website/blog to embed this press release.

Comments

Post new comment

1 + 0 =

To prevent automated spam submissions leave this field empty.